Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Confirmed: Mediterranean diet helps heart patients live longer, healthier lives
The diet, named after the traditional eating habits of Greece and Italy, is already known for its benefits to the general public. Its impact on heart patients, however, was less clear.
FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information
The FDA finalized four Class I recalls related to safety concerns first reported by Abbott in November. Meanwhile, a Florida man who uses these sensors to manage his diabetes has already filed a lawsuit over the issue.
FDA clears Medtronic’s new smart diabetes management app
Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.
‘Mental clarity’ supplement recalled due to risk of cardiovascular events, suicidal thoughts
This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately.
CBD shows early potential to treat heart disease
Early evidence suggests CBD could help clinicians treat pericarditis, myocarditis and other significant heart conditions. Additional research is still required, however, including many more clinical trials.

Confirmed: Mediterranean diet helps heart patients live longer, healthier lives

The diet, named after the traditional eating habits of Greece and Italy, is already known for its benefits to the general public. Its impact on heart patients, however, was less clear.

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system

FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information

The FDA finalized four Class I recalls related to safety concerns first reported by Abbott in November. Meanwhile, a Florida man who uses these sensors to manage his diabetes has already filed a lawsuit over the issue.

Medtronic has received U.S. Food and Drug Administration (FDA) clearance for the MiniMed Go Smart Multiple Daily Injection system.

FDA clears Medtronic’s new smart diabetes management app

Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.

The U.S. Food and Drug Administration (FDA) has announced that Modern Warrior is recalling all lots of its Modern Warrior Ready capsules, a dietary supplement marketed as a way to boost metabolism, improve brain function and reduce cravings.

‘Mental clarity’ supplement recalled due to risk of cardiovascular events, suicidal thoughts

This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately.

CBD shows early potential to treat heart disease

Early evidence suggests CBD could help clinicians treat pericarditis, myocarditis and other significant heart conditions. Additional research is still required, however, including many more clinical trials.

Trump regrets undergoing CT to evaluate heart health—cardiologist still baffled by his aspirin use

President Trump, 79, says he is still in excellent health. He also has no intention of cutting down on the high dose of aspirin he takes each day.

Medtronic’s MiniMed 780G automated insulin delivery system

Medtronic’s diabetes spin-off files for IPO

Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Is IVL safe for patients with diabetes?

New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.